• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大规模筛查计划对宫颈癌风险的影响。

Effect of a mass screening program on the risk of cervical cancer.

作者信息

Hakama M, Räsänen-Virtanen U

出版信息

Am J Epidemiol. 1976 May;103(5):512-7. doi: 10.1093/oxfordjournals.aje.a112253.

DOI:10.1093/oxfordjournals.aje.a112253
PMID:1274953
Abstract

In Finland, the organized mass screening program for the early detection of cervical cancer covers, with few exceptions, all women between the ages of 30 and 55 every fifth year. On the basis of material originating from the Finnish Cancer Registry it was estimated that the probability for a woman aged 30-59 to experience frankly invasive cervical cancer was 0.010 before the screening program, and 0.002 after the first screening. The corresponding probability estimate was 0.022 for pre-invasive lesions subjected to operative treatment. On the assumption that the same relationship applies beyond this age group it was estimated that from 28-39% of the pre-invasive cases progress to invasive cervical cancer, and that 21% of the frankly invasive cases are preceded by a pre-invasive stage of shorter duration than the time period between the screenings, or have no preclinical stage.

摘要

在芬兰,宫颈癌早期检测的有组织大规模筛查计划几乎覆盖了所有30至55岁的女性,每五年进行一次。根据芬兰癌症登记处提供的资料估计,在筛查计划实施前,30至59岁女性患明显浸润性宫颈癌的概率为0.010,首次筛查后为0.002。接受手术治疗的癌前病变的相应概率估计为0.022。假设这种关系适用于该年龄组以外的人群,据估计,28%至39%的癌前病例会发展为浸润性宫颈癌,21%的明显浸润性病例之前存在癌前阶段,其持续时间短于两次筛查之间的时间间隔,或者没有临床前期。

相似文献

1
Effect of a mass screening program on the risk of cervical cancer.大规模筛查计划对宫颈癌风险的影响。
Am J Epidemiol. 1976 May;103(5):512-7. doi: 10.1093/oxfordjournals.aje.a112253.
2
Long-term mass screening in uterine cervical carcinoma eradication strategy.子宫颈癌根除策略中的长期大规模筛查
Jpn J Clin Oncol. 1990 Jun;20(2):134-8. doi: 10.1093/oxfordjournals.jjco.a039377.
3
Treatment of pre-invasive conditions during opportunistic screening and its effectiveness on cervical cancer incidence in one Norwegian county.挪威一个郡在机会性筛查期间对癌前病变的治疗及其对宫颈癌发病率的影响。
Int J Cancer. 1997 Mar 28;71(1):4-8. doi: 10.1002/(sici)1097-0215(19970328)71:1<4::aid-ijc2>3.0.co;2-y.
4
Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.芬兰和荷兰的宫颈癌大规模筛查计划及趋势
Int J Cancer. 2008 Apr 15;122(8):1854-8. doi: 10.1002/ijc.23276.
5
Optimization of cervical cancer screening.宫颈癌筛查的优化
Cancer Causes Control. 1992 Mar;3(2):125-36. doi: 10.1007/BF00051652.
6
Epidemiological evidence for two components of cervical cancer.宫颈癌两个组成部分的流行病学证据。
Br J Obstet Gynaecol. 1981 Mar;88(3):209-14. doi: 10.1111/j.1471-0528.1981.tb00970.x.
7
Effect of population screening for carcinoma of the uterine cervix in Finland.芬兰子宫颈癌人群筛查的效果
Maturitas. 1985 May;7(1):3-10. doi: 10.1016/0378-5122(85)90029-5.
8
Therapy for cervical cancer detected by mass screening.通过大规模筛查发现的宫颈癌的治疗。
Tohoku J Exp Med. 1983 Dec;141(4):451-6. doi: 10.1620/tjem.141.451.
9
Mass screening for cervical carcinoma in Finland. Organization and effect on morbidity and mortality.芬兰宫颈癌大规模筛查。组织情况及其对发病率和死亡率的影响。
Ann Chir Gynaecol Fenn. 1974;63(2):104-12.
10
Risk of cervical cancer among an electrocoagulated population.接受电凝治疗人群患宫颈癌的风险。
Am J Obstet Gynecol. 1978 Jul 1;131(5):533-8. doi: 10.1016/0002-9378(78)90115-1.

引用本文的文献

1
Genetic Biomarkers Associated with Dynamic Transitions of Human Papillomavirus (HPV) Infection-Precancerous-Cancer of Cervix for Navigating Precision Prevention.用于精准预防的与人类乳头瘤病毒(HPV)感染-宫颈癌前病变-宫颈癌动态转变相关的遗传生物标志物
Int J Mol Sci. 2025 Jun 23;26(13):6016. doi: 10.3390/ijms26136016.
2
Exposure Definition in Case-Control Studies of Cervical Cancer Screening: A Systematic Literature Review.宫颈癌筛查病例对照研究中的暴露定义:系统文献回顾。
Cancer Epidemiol Biomarkers Prev. 2021 Dec;30(12):2154-2166. doi: 10.1158/1055-9965.EPI-21-0376. Epub 2021 Sep 14.
3
Cervical Cancer Screening Services at Tertiary Healthcare Facility: An Alternative Approach.
三级医疗机构的宫颈癌筛查服务:一种替代方法。
Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1265-1269. doi: 10.31557/APJCP.2019.20.4.1265.
4
Do Cervical Cancer Patients Diagnosed with Opportunistic Screening Live Longer? An Arkhangelsk Cancer Registry Study.机会性筛查诊断的宫颈癌患者是否活得更长?阿尔汉格尔斯克癌症登记研究。
Int J Environ Res Public Health. 2017 Nov 26;14(12):1500. doi: 10.3390/ijerph14121500.
5
Epidemiology of cervical cancer with special focus on India.宫颈癌的流行病学,特别关注印度。
Int J Womens Health. 2015 Apr 16;7:405-14. doi: 10.2147/IJWH.S50001. eCollection 2015.
6
Evaluation of vaginal cytology in female sex-workers: A study in a tertiary hospital of eastern India.印度东部一家三级医院对女性性工作者阴道细胞学的评估研究。
J Cytol. 2014 Jan;31(1):7-10. doi: 10.4103/0970-9371.130613.
7
50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence.50 年的北欧国家筛查:定量评估对宫颈癌发病率的影响。
Br J Cancer. 2014 Aug 26;111(5):965-9. doi: 10.1038/bjc.2014.362. Epub 2014 Jul 3.
8
Prevalence of cervical dysplasia in western Uttar Pradesh.印度北方邦西部宫颈发育异常的患病率。
J Cytol. 2013 Oct;30(4):257-62. doi: 10.4103/0970-9371.126659.
9
The value of improving failures within a cervical cancer screening program: an example from Norway.改善宫颈癌筛查项目中漏诊情况的价值:来自挪威的一个例子。
Int J Cancer. 2014 Oct 15;135(8):1931-9. doi: 10.1002/ijc.28838. Epub 2014 Mar 20.
10
Answering human papillomavirus vaccine concerns; a matter of science and time.解答人乳头瘤病毒疫苗相关疑问;这是一个关乎科学和时间的问题。
Infect Agent Cancer. 2013 Jun 12;8(1):22. doi: 10.1186/1750-9378-8-22.